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Abstract 
BACKGROUND: The hyperparathyroidism (HPT) is a condition in which the parathyroid hormone (PTH) levels in 
the blood are increased. HPT is categorised into primary, secondary and tertiary. A rare entity that occurs in the 
lower jaw in association with HPT is the so-called brown tumour, which an osteolytic lesion is predominantly 
occurring in the lower jaw. It is usually a manifestation of the late stage of the disease. Osteosclerotic changes in 
other bones are almost always associated with renal osteodystrophy in secondary HPT and are extremely rare in 
primary HPT. This article reports a rare case of a brown tumour in the mandible as the first sign of a severe 
primary HPT, associated with osteosclerotic changes on the skull. 
CASE REPORT: A brown tumour in the mandible was diagnosed in 60 - year old female patient with no previous 
history of systemic disease. The x - rays showed radiolucent osteolytic lesion in the frontal area of the mandible 
affecting the lamina dura of the frontal teeth, and skull osteosclerosis in the form of salt and pepper sign. The 
blood analyses revealed increased values of PTH, calcitonin and β – cross-laps, indicating a primary HPT. The 
scintigraphy of the parathyroid glands showed a presence of adenoma in the left lower lobe. The tumour lesion 
was surgically removed together with the lower frontal teeth, and this was followed by total parathyroidectomy. 
The follow - up of one year did not reveal any signs of recurrence. 
CONCLUSION: It is critical to ensure that every osteolytic lesion in the maxillofacial region is examined 
thoroughly. Moreover, a proper and detailed systemic investigation should be performed. Patients should undergo 
regular check-ups to prevent late complications of HPT. 
 
 
 
Introduction 
 
The main hormone that regulates the calcium 
metabolism in the body is the parathyroid hormone 
(PTH). It is secreted by the parathyroid glands, and its 
release is dependent on the plasma concentration of 
ionised calcium. The lower the concentration, the 
higher the secretion of PTH is. The primary function of 
PTH is to normalise the level of calcium in the blood. It 
demonstrates its activity by activation of osteoclasts, 
subperiosteal bone resorption, catalysing the vitamin 
D synthesis in the kidneys and increasing the 
reabsorption of calcium in the kidneys.  
The hyperparathyroidism (HPT) is a condition 
where PTH is increasingly released from the 
parathyroid glands. It is categorised into primary, 
secondary and tertiary [1]. 
The primary HPT is, in most of the cases, a 
result of a gland adenoma, and rarely occurs due to 
malignancy [2]. It is characterised by hypercalcemia. 
The secondary HPT is a consequence of the 
hypocalcemia, where the glands increase the 
production of the hormone to mobilise the calcium 
from the bones to correct the condition [3]. The tertiary 
HPT is a condition developed after a long period of 
increased PTH secretion from the glands. Additionally, 
another form of HPT exists, known as a 
paraneoplastic syndrome or pseudohypo-
parathyroidism, in which PTH is released into the 
bloodstream from ectopic parathyroid - like a gland. 
A rare entity that occurs in the lower jaw is the 
so-called brown tumour, which is an osteolytic, cystic - 
Dental Science - Case Report 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
  2                                                                                                                                                                                                  https://www.id-press.eu/mjms/index 
 
 
like lesion filled with soft tissue composed of 
fibrovascular stroma and giant cells [4]. They are 
called brown tumours because of the colour that they 
get as a result of the haemorrhage in the tissue, and 
the hemosiderin deposits [5][6] The frequency of 
occurrence of brown tumours in the primary and 
secondary HPT is 4.5% and 1.5 – 1.7%, respectively. 
The overall incidence is 0.1% [7]. It is thought that 
brown tumours are a late manifestation of HPT and 
nowadays they are not as often detected as before 
due to the early diagnosis of the endocrinologic 
condition. Osteosclerotic changes in other bones are 
almost always associated with renal osteodystrophy in 
secondary HPT and are extremely rare in primary 
HPT [8][9][10]. They are usually limited to the pelvis, 
spine, skull and ends of the long bones.  
This article reports a rare case of a brown 
tumour in the mandible as the first sign of a severe 
primary HPT, associated with osteosclerotic changes 
on the skull with the so-called salt and pepper sign. 
 
 
Case report 
 
Sixty-year-old female referred to our clinic, 
complaining about discomfort and swelling in the front 
area of the mandible. The obtained medical data did 
not show any history of chronic or malignant 
conditions. According to the patient, the swelling in the 
vestibulum was gradually increasing with time. The 
patient did not complain about pain, stiffness or other 
subjective symptoms. The clinical investigation 
revealed solid, rounded formation in the vestibulum 
extended between the canine teeth in the lower jaw. 
There were no fluctuations, no tenderness and no 
colour or surface changes of the mass. No fistulas or 
pus were detected. All the lower incisors were mobile, 
indicating loss of the surrounding bone. Further 
examination tools were used: a complete blood 
analysis and panoramic x-ray were performed.  
The blood analysis showed increased values 
of parathyroid hormone, osteocalcin and β - cross-
laps (Table 1). No other significant alterations of the 
blood parameters were present. The x-ray showed a 
cystic-like radiolucent lesion in the mandible, 
extending from the roots of the second premolars from 
the one side to the second premolars to the other side 
(Figure 1). The lesion almost reached the lower edge 
of the body of the lower jaw. A severe reduction of the 
bone density was observed in the affected area, as 
well. Also, the lamina dura of the incisors and right 
canine was also affected. The similar lesion was 
detected on the x-ray in the left distal area of the 
mandible body, but that finding was not associated 
with any clinical signs or symptoms.  
 
Figure 1: A) The panoramic x-ray shows a huge radiolucent cystic - like 
change in the frontal area of the mandible (red arrows), extending to the 
lower edge of the mandible and affecting the lamina dura of the lower frontal 
teeth; B) The red arrows on the lateral x-ray of the skull show osteosclerotic 
changes on the calvaria (salt and pepper sign) 
 
The profile x-ray of the skull showed the 
lesions of the mandible from another perspective, but 
it also revealed osteosclerotic changes on the 
calvaria. These changes were addressed as salt and 
pepper sign.  
Table 1: Laboratory tests and findings in the patient that lead 
to set the diagnosis 
Tested parameter Found value Normal range 
PTH 1312 pg/ml 15-65 pg/ml 
Osteocalcin 56.4 ng/ml 15-46 ng/ml* 
Β - crossLaps 1.57 ng/ml 0.556 ng/ml* 
Total Vit. D (25 - Hydroxyvitamin D) 30.88 nmol/l 25-110 nmol/l 
Na
+
 141 mmol/l 130-150 mmol/l 
K
+
 4.2 mmol/l 3.3-5.6 mmol/l 
Ca
2+
 1.64 mmol/l 1.16-1.29 mmol/l ** 
*in postmenopausal women; **in adults 60-90-year old. 
 
Considering the obtained data from the blood 
and x-ray analyses, a working diagnosis of a brown 
tumour in the mandible as a result of HPT was set. 
Two-Phase scintigraphy of the thyroid and parathyroid 
glands was performed, and it showed accumulation of 
the Tc99m beyond the lower pole of the left thyroid 
lobe, extending sub-clavicular and posteriorly (Figure 
2).  
 
Figure 2: The scintigraphy of the parathyroid glands show accumulation of the 
isotope in the lower left parathyroid lobe, extending below the clavicle and 
posteriorly. This finding indicates a presence of gland adenoma 
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The extension was with a diameter of 4 cm, 
indicating a presence of adenoma of the parathyroid 
gland. In the absence of signs of renal failure and 
ectopic parathyroid glands, the HPT was determined 
as primary. The treatment plan included surgical 
removal of a brown tumour from the frontal area in the 
mandible, followed with excision of the gland 
adenoma (Figure 3).  
 
Figure 3: A) Preoperative look of the affected area. The lower frontal teeth 
were extracted due to severe mobility; B) Intraoperative view of a brown 
tumour (clamped lesion); C) A tumour was excised completely in one piece  
 
We extracted the lower incisors and right 
canine due to the severe mobility. An intraoral buccal 
vestibular incision was made, and the mass was 
removed in one piece. The histological examination 
proved the working diagnosis of a brown tumour. The 
adenoma of the parathyroid gland was also removed, 
after which the level of PTH was gradually decreasing. 
No signs of recurrence of a tumour were noted in the 
following year. 
 
 
Discussion 
 
The clinical presentation of HPT in the early 
stages is not often abundant. Later, it may include 
renal calculi, osteoporosis, peptic ulcers, pancreatitis 
or neuropsychiatric symptoms [11][12][13][14]. Since 
HPT changes the bone metabolism, the bones are 
likely to become affected. Most involved bones are the 
ribs, clavicles, pelvic girdle and the lower jaws [15]. 
The brown tumours in the jaws associated 
with HPT represent reparative granuloma, rather than 
a true neoplastic process. These changes are due to 
the reduction of the bone density and its filling with 
granulation tissue. The lytic lesions on the bones, 
including the jaws and skull, as showed in our case, 
are signs of the terminal stadium of HPT. The 
technological advancements and the possibility of 
early diagnosis greatly decreased the incidence of 
these findings [16]. Thus, they are rarely seen in the 
developed countries [17]. However, this case showed 
that they still can represent a clinical entity that 
requires great attention. 
A brown tumour associated with primary HPT 
is more frequently seen in the lower jaw, rather than in 
the upper jaw. The simultaneous finding in both jaws 
is extremely rare [18]. The females are three times 
more likely to be diagnosed with a brown tumour than 
the males when the disease is progressing to the late 
stage [3]. A brown tumour in this case, in addition to 
the bone resorption of the body of the mandible, 
affected the periodontal apparatus of the frontal teeth 
which lead to the severe mobility. This loss of the 
surrounding bone of the teeth was also demonstrated 
in previous studies and was a radiologic feature within 
6 - 55% [15][19]. 
The diagnosis of a brown tumour cannot be 
solely set by the histological findings because they are 
not specific for this condition. The usual findings are 
mononuclear stroma cells accompanied by 
multinuclear giant cells [20][21]. These giant cells can 
be found in other lesions, like aneurismal bone cysts, 
giant cells granulomas, cherubism and Langerhans 
histiocytosis [22][23]. Therefore, the definite diagnosis 
should incorporate the clinical, biochemical, 
histological and radiological signs. The increased 
levels of PTH and osteocalcin indicated an increased 
release of the hormone from the glands. The level of 
calcium was also elevated due to the bone resorption, 
as an effect of the action of PTH. Β - cross-laps, which 
are a specific marker for degradation of mature type I 
collagen during bone resorption, were also elevated. 
Furthermore, the scintigraphy showed increased 
uptake of the used isotope in the right parathyroid 
glands. The skull changes were a sign of general 
reduction in the bone density. All these findings, 
accompanied with the lytic lesions seen on the 
radiographs, depicted the condition of primary HPT.  
The principle treatment of the primary HPT 
associated with bone changes and highly increased 
blood markers is partial or total parathyroidectomy. It 
is assumed that after the removing of the reason for 
HPT, the bone changes will spontaneously regress 
[13][14][24,25]. This claim is supported particularly for 
the small tumours and has been demonstrated in 
previous studies [19]. However, in cases when the 
tumour dimensions interfere with the function and 
every - day activities of the patient, the surgical 
removal is a reasonable solution [26][27]. This was 
the case with our patient. The growth of the lesion 
severely damaged the frontal teeth and was a reason 
for considerable discomfort during eating and even 
not taking any action. After the surgical removal of the 
jaw lesion and the gland adenoma, no signs of 
recurrence were detected in the follow up of one year.  
This report shows that HPT may not be 
diagnosed until the late stages of the disease, despite 
the technological advancements and available 
diagnostic tools. The huge brown tumour in the 
mandible and the osteosclerotic skull changes were 
the initial signs of primary HPT in our patient. 
Therefore, it is critical to perform a detailed systemic 
investigation in the cases of suspect osteolytic lesions 
in the maxillofacial area. Moreover, rising the 
awareness and emphasising the importance of regular 
check-ups are also encouraged. These measures will 
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prevent the late complications of the disease that can 
be easily diagnosed in its early stages.  
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